[VRTX] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
03-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 44.87%
YoY- 79.04%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 458,706 413,783 431,608 398,080 417,935 309,816 166,076 96.25%
PBT 20,306 -42,034 -18,021 -30,617 -77,829 -92,486 -190,861 -
Tax -7,453 503 18,130 5,485 -1,379 1,330 30,131 -
NP 32,945 -41,841 -64,525 -41,631 -75,512 -95,149 -188,848 -
Tax Rate 36.70% - - - - - - -
Total Cost 425,761 455,624 496,133 439,711 493,447 404,965 354,924 12.83%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 7.18 -10.11 -14.95 -10.46 -18.07 -30.71 -113.71 -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS 0.13 -0.17 -0.26 -0.17 -0.31 -0.39 -0.78 -
EPS Diluted 0.13 -0.17 -0.26 -0.17 -0.31 -0.39 -0.78 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.